Introduction
The U.S. Environmental Protection Agency (U.S. EPA) Office of Children's Health Protection held a conference in September on Preventable Causes of Cancer in Children. The conference helped us to evaluate our knowledge about and efforts in preventing environmentally related cancers in children and to determine the future directions of our additional efforts.
We know little about how chemicals in the environment relate to risks of childhood cancer. We do know that certain types of childhood cancers are increasing, but we do not know why. In general, the amount and quality of the information on carcinogenic and other risks depend on the chemicals being discussed. Generally, we have adequate data to screen chemicals for potential carcinogenic and other hazards for drugs, food additives, and pesticides. Although it is often necessary to obtain additional data for assessing children's risks to these chemicals, we have little information about other chemicals regulated under the Toxic Substances Control Act (TSCA) (1) We have more knowledge of carcinogenic and other health effects of chemicals on fetuses, infants, and children for drugs than for any other class of chemicals, and it is to this body of knowledge that environmental regulators have looked to help screen similar environmental chemicals for potential carcinogenic and other toxic effects. An example of a carcinogenic drug that may be similar to other environmental chemicals that mimic hormones is diethylstibestrol (DES), a strong estrogenic drug taken by thousands of women to avoid miscarriages. DES produced developmental changes in some of the fetuses that resulted in an unexpectedly large number of cervical and vaginal cancers in the adult daughters (3, 4) .
A 1992 compilation of research on how children differ from adults in their exposure and susceptibility to chemicals concluded that in some cases there may be no difference in the response of adults and children. In other cases, different physiological and metabolic factors, pharmacokinetics, and diet, behavior patterns, and other influences can make children either more or less susceptible to the effects of chemicals than adults (5) .
For years, in setting tolerances for pesticides, the U.S. EPA had been adding an additional 10- Table 1 , the U.S. EPA has already taken action to ban or restrict the use of a number of these compounds. It is important to note that a pesticide's classification, or hazard, is only part of the risk equation. We must also consider the likely exposure to the pesticide. We will reassess all these pesticides under the FQPA, and those judged to be probable human carcinogens or possible human carcinogens with quantifiable risks will be in the first group reviewed (8) . As overwhelming as this is, for the majority of the approximately 3000 high-productionvolume industrial chemicals produced in the United States in 1996, we have little or no publicly available hazard screening data (11) . These chemicals, nonpolymers produced in quantities of more than 1 million pounds per year, are found in the workplace and in thousands of consumer products.
Even fewer data are available for the remainder of the some 70,000 chemicals on the U.S. EPA inventory.
Food Quality Protection Act
A new era of protection from carcinogenic risks has arrived for children, and one of the major driving forces is the 1996 FQPA (8) . Under the new food quality law, all tolerances must meet a "reasonable certainty of no harm" standard. To make this finding, the U.S. EPA now must take into account the aggregate impact of all nonworker-related sources and pathways of exposure to a pesticide, i.e., to the combined exposure to a pesticide through all dietary routes, including drinking water, as well as exposures resulting from use in households and on lawns. We must also consider cumulative effects of a pesticide and other substances that share common mechanisms of toxicity.
We now must add an additional 10-fold safety factor to account for prenatal or postnatal developmental toxicity. The U.S. EPA also must consider all available information on in utero effects. For threshold effects, risks generally must fall below one in a million (10-6). For nonthreshold effects, the U.S. EPA adds a 100-fold uncertainty factor where prenatal/postnatal toxicity and exposure data for children are such that the risks for children have not been well defined and may be greater than the risks for adults. The U.S. EPA may make a finding, based on reliable data, that a smaller uncertainty factor is protective. This situation arises either when hazards for children are well enough characterized that the U.S. EPA conduded that the pesticide is not more hazardous for children than for adults or when the risks for children are well understood and constitute the basis for the U.S. EPA's risk assessment. The agency also must screen for and take into account chemicals that mimic hormones, so-called endocrine disrupters, some of which are known to be probable or possible human carcinogens.
These were key steps the NAS said were needed to protect infants and children from carcinogenic and other risks posed by pesticides. For the past year, the U.S. EPA has been working with the scientific community to conduct new research and to establish new testing and risk assessment methods to take these factors into account. All the requirements took effect with the law's enactment in August 1996, so the U.S. EPA is using its best scientific judgment in making decisions as the new data and risk assessment methods are being developed.
For the past year, with guidance from its Science Advisory Panel (SAP), the U.S. EPA has been learning how to conduct risk assessments taking into account the new requirements. The SAP was established under the Federal Advisory Committees Act to review all U.S. EPA scientific work under the new food quality law.
The SAP has reviewed and approved our approach to assessing cumulative risks of pesticides that act via a common mechanism of toxicity. The International Life Sciences Institute is helping the U.S. EPA to identify organophosphate chemicals having common mechanisms of toxicity. We are also gathering this information on carbamate pesticides. We hope this year, working with our stakeholders, to establish a process to evaluate the risks from cumulative exposures to the organophosphate pesticides. In any case where we currently have reliable evidence that pesticides share common mechanisms of toxicity, we will perform a cumulative risk assessment and make a decision based on the results. This will be a powerful tool in avoiding preventable risks, including cancer risks.
Perinatal Testing for Carcinogenesis
Over the years there has been much concern about whether current cancer testing guidelines (12) adequately assess risks for children. These were highlighted by the NAS report, and even before the passage of the new food quality law the U.S. EPA had updated and improved guidelines for prenatal developmental and reproductive toxicity data. Last Administration (U.S. FDA) for food color additives (13) . Like the U.S. FDA, the U.S. EPA will be setting criteria to determine when in utero tests will be required (14) . In both perinatal and standard carcinogenicity tests, we found that qualitatively the same tumors were produced, except in the case of DES (15) (16) (17) . Quantitatively, we found that perinatal dosing may or may not result in a higher tumor incidence than standard carcinogenic tests. When there is a greater response, it is difficult to determine if the effect is due to an enhanced sensitivity during development or to a greater total dosing, but increases were in the range of 20 to 30%. We found also that combined perinatal and adult exposure sometimes reduces the latency period for tumors to develop, and that enhanced effects were generally seen for genotoxins and also for DES.
In addition, there were several other factors that the U.S. EPA considered in the development of its proposed policy. First, DES showed that induction of developmental abnormalities during gestation may predispose to differential carcinogenic effects. This leads to the conclusion that environmental endocrine disruptors may pose unique susceptibilities for children. Second, age-related differences in the ability to metabolize chemicals can alter the sensitivity to carcinogens. This difference can go in the direction of making a child either more susceptible (e.g., cannot metabolize the carcinogen) or less susceptible (e.g., cannot form the carcinogenic metabolite). Third, genetic toxicology test results do not consistently predict the need for perinatal testing. However, enhanced mutations may occur during development because of significant cell division or reduced DNA repair with immature repair systems. Fourth, the immune system is not fully functional throughout development, until the third month of life.
Based on these considerations and others, the U.S. EPA has proposed a set of criteria for which chemicals will require in utero testing, which were reviewed by the SAP along with reviewers from the U.S. EPA Science Advisory Board (14) . The In making decisions on the chemicals that will require in utero testing, the U.S. EPA will be using a weight-of-evidence approach based on a careful evaluation of factors in combination. We will consider the nature of the toxic response, the adequacy of the exposure assessment for infants, and the potential dose-response relationships.
Perinatal carcinogenicity study protocols will be designed on a chemical-by-chemical basis. This is because they pose unique problems, such as determination of appropriate dosage levels. The proposed factors will be evaluated from time to time for their adequacy; appropriate modifications will be made as new information becomes available. Additional testing could be required at any time, but an important opportunity will be registration renewal, which must occur for all pesticides every 15 years under FQPA. Clearly, however, more research is warranted in this area to develop better methods to predict carcinogenic risks due to prenatal and neonatal exposures.
Pesticide Tolerance Reassessment
More immediately, the new food law sets a 10-year schedule for the U.S. EPA to review about 10,000 existing tolerances for pesticide residues on food. Within the next 2 years, the U.S. EPA will review the first third, or about 3300 tolerances, that pose the worst risks. The first group will include the organophosphate, carbamate, and organochlorine classes, as well as chemicals that may be human carcinogens.
As the U.S. EPA reviews new and existing pesticides registrations under the new law, we will find that some-considering their aggregate exposures and cumulative effects on children-pose more than a negligible risk. So we will be canceling registrations for some existing pesticide uses and denying requests for new pesticides than may have been allowed under previous pesticide laws. The important point here is that over time, pesticides posing the greatest carcinogenic and other health risks will be replaced by safer conventional pesticides or alternatives, such as integrated pest management, biological controls, and biotechnology.
The new law's provisions already are prompting decisions that we probably would not have made under the previous law. For example, we denied the renewal of a tolerance for residues of the fungicide iprodione on cotton seed, because after adding the additional risk from drinking water, the cancer risk was too high (18) . We also denied a request by the state of California for an emergency exemption to use iprodione on pistachio nuts due to too great a cancer risk. Similar actions are pending. As you can see, our greatest challenge is to develop the new information and scientifically valid risk assessment methods that we need to do the job that we have been given.
Industrial Chemicals
So we are succeeding in our efforts to assess and reduce carcinogenic risks posed by pesticides from children's diets, as well as from homes, schools, and other unintended pathways. However, we have made far less progress in defining carcinogenic and other risks posed by many other chemicals that our children are exposed to in their environments.
Our inability to judge the safety of so many environmental chemicals was outlined by the NRC in 1984 (19) , and by the Office of Technology Assessment (OTA) (20) shortly before it was abolished. Using the NRC's test methods of sampling highproduction-volume chemicals, the Environmental Defense Fund (EDF) recently came to the same conclusionthat we do not have basic health effects data for the majority of nonpesticidal industrial chemicals produced in the greatest quantities in the United States (11) . Although we have not yet completed a detailed review of the EDF report, the results are very close to the U.S. EPA's statistics for chemicals.
The EDF study indicated that the most basic toxicity testing results cannot be found in the public record for 71% of the approximately 3000 high-production-volume chemicals in commercial use. The study was based on a random sample of 100 chemicals imported or produced in quantities of more than 1 million pounds per year. In measuring whether a chemical had qualified as having hazard identification available, the study used the definition of minimum screening data required by the international chemical screening and testing program of the Organisation for Economic Co-operation and Development Program (OECD).
The study's sample also indicated that the majority of high-production-volume chemicals have been tested only for their ability to cause mutations and birth defects. Carcinogenicity tests have not been conducted on 63% of the high-productionvolume chemicals sampled.
Of course, many of the exposures to these widely used chemicals can be chronic. But, while 90% of the high-productionvolume chemicals had been tested for acute toxicity, less than half of them had been tested for any form of chronic toxicity.
The study contained other dismaying findings. Forty-seven of the 100 highproduction-volume chemicals sampled were included in the Toxics Release Inventory (TRI) and therefore are being emitted into air, land, and water in quantities of more than 10,000 pounds per year. Toxicity data was available for less than half of the TRI chemicals. Also, almost 60% of the chemicals sampled that met the U.S. EPA criteria for bioaccumulation and persistence did not meet basic screening requirements for health hazard data.
The clear conclusion from the 1984 NRC study, the OTA, and recent EDF study is not that almost 75% of all the commercial high-production-volume chemicals are unsafe, but that we have no reliable basis on which to determine if they are safe or not. Therefore, we are flying blind, and do not know where we should be making efforts to reduce their use and potential risks, including carcinogenic risks. We know even less about the remainder of the 70,000 chemicals on the U.S. EPA inventory.
We need to find ways to move ahead with screening these high-productionvolume chemicals. The U.S. EPA is developing a toxics agenda-a dear mission and coherent strategy to systematically identify and act on the most serious chemical risks. Our highest priority targets are those chemicals to which children are most exposedchemicals in their homes, schools, and play areas. Through the Toxics Agenda we are seeking to lay the basis for initiatives from industry, the public, and government to assess chemicals and make toxicity data available.
Clearly the 3000 very high-productionvolume (> 1 million lb/year) nonpolymeric chemicals have the highest priority for action. Of these, only 500 have had testing under the TSCA-half of these since 1992 (21) . Clearly more testing is needed. We would like to see the chemical industry increase its support of the OECD screening information data sets program, which is assessing high-volume chemicals on a cooperative international basis (22) . The purpose of this effort is to target risks and those chemicals that require further study. A key advantage of this approach is that its testing costs are shared with other countries, which should speed the task. We also would like to see stronger authority for the U.S. EPA to require testing, and a more specific agenda for testing. Testing for endocrine disruptors, as required in the Safe Drinking Water Act (23) and the FQPA (8) , is a good beginning.
This year, the U.S. EPA plans to focus several initiatives at reducing children's exposures to toxics and potential carcinogens. One is an agencywide effort to target reductions in all media environmental programs persistent bioaccumulative toxic chemicals, such as dioxin, polychlorinated biphenyls, and mercury, that also may be carcinogens. We also plan to expand our consumer labeling initiative (24) beyond pesticides to labels on household and other consumer products, such as deaning agents and latex paint, with the goal of providing more readily understandable information on hazards, especially to children.
Along the same lines, the U.S. EPA plans to make protection of indoor environments a higher priority. This effort is gaining momentum. Almost every program and regional office is involved in planning a strategy that will make the most of our resources and existing legislative authorities. The effort will include protection from indoor air pollution as well as other indoor health hazards.
We know that radon is estimated to account for 7000 to 30,000 lung cancer deaths annually (25) , and that environmental tobacco smoke is estimated to account for 3000 annual lung cancer deaths in nonsmokers (26) . We know that some consumer and commercial products and building materials emit chemicals that are suspected carcinogens (27) . We do not know how many cases of childhood cancers are caused by these exposures, but we are focusing our efforts on protecting children from exposures that pose the highest risks.
On another initiative that I mentioned, we plan to begin to screen chemicals for their ability to mimic hormones. We will be looking at pesticides, which I mentioned, and at water contaminants. A federal advisory committee, the Endocrine Disruptor Screening and Testing Advisory Committee, is developing an implementation plan that is due in August 1998. Screening is slated to begin in 1999.
These initiatives are promising, and we are taking major steps to give our children added protections against cancers from pesticides. But we have a long way to go in understanding cancer risks posed by industrial chemicals, and therefore, we are far from being able to effectively regulate their carcinogenic risks to children.
